6 November 2026 (Friday)
Immunology Course for Respiratory Physicians
| Time | Session |
|---|---|
|
11:30 – 12:00 |
Registration |
|
12:00 – 12:30 |
Introduction – Biologics and Monoclonal Antibody Therapies: Foundations for Modern Medicine |
|
12:30 – 15:30 |
Session (1) – The Complementary Roles of Adaptive and Innate Immunity |
|
Brief Overview of Adaptive Immunity (Cells and Pathways) |
|
|
Brief Overview of Innate Immunity (Cells and Pathways) |
|
|
Brief Overview of Immunodeficiency Disorders (and Investigation) |
|
|
15:30 – 16:00 |
Coffee Break and Exhibition |
|
16:00 – 17:30 |
Session (2) – Clinical Illustrations of the Roles Played by Immune System in Airway Disorders |
|
A Patient with Recurrent Airway Infections |
|
|
A Patient with Persistent Airway and Blood Eosinophilia |
|
|
A Patient with Severe Allergies and Anaphylaxis |
|
|
A Patient with Skin Manifestations in Addition to Respiratory Symptoms |
|
|
17:30 – 18:00 |
Coffee Break and Exhibition |
|
18:00 – 19:00 |
Session (3) – Case Discussion Chester Lai (Hong Kong) |
|
19:00 – 19:05 |
Closing Remarks |
7 November 2026 (Saturday)
Airway Disease Symposium
| Time | Programme | |
|---|---|---|
|
08:30 – 09:00 |
Registration |
|
|
09:00 – 10:00 |
Meet the Professors for Respiratory Physicians |
Certificate Course for Allied Health Professionals (AHPs) |
|
|
Advanced Imaging to Guide Therapy in Severe Asthma
|
Asthma and COPD in Hong Kong: Essentials of Diagnosis and Modern Management Bronchiectasis Lung Function Testing including Bronchial Challenge Test, Impulse Oscillometry & Exhaled Nitric Oxide |
|
10:00 – 10:15 |
Coffee Break and Exhibition |
|
|
10:15 – 10:30 |
Coffee Break and Exhibition |
|
|
10:30 – 11:30 |
Meet the Professors for Respiratory Physicians |
Hands-on Workshops for Allied Health Professionals (AHPs) & Physicians |
|
Biologics for Airway Diseases: Biologics for Airway Diseases: Selection, Switching Strategies, and Combination Therapy |
Station 1: Pulmonary Function Test Station 2: Forced Oscillometry & Exhaled Nitric Oxide Station 3: Skin Prick Tests and Inhaler Techniques |
|
|
11:30 – 12:30 |
Meet the Professors for Respiratory Physicians |
|
|
Research and Management Gaps in Airway Diseases in the Region, How to Address These Issues, and Sharing of Research Experience |
||
|
12:30 – 13:45 |
Lunch Break |
|
|
13:45 – 15:40 |
Symposium (1) – Asthma & COPD: Unmet Needs & How to Get Them Met? |
|
|
Updates and Unmet Needs in the Management of Acute Exacerbations of Asthma and COPD |
||
|
Environment and Asthma: Friend or Foe |
||
|
Recognizing the Importance of Airway Mucus in Asthma and COPD |
||
|
COPD Progression: Can We Predict and Prevent Its Progression? |
||
|
15:40 – 16:10 |
Coffee Break and Exhibition |
|
|
16:10 – 17:55 |
Symposium (2) – Current & Emerging Management for Airway Diseases |
|
|
Clinical Remission in Asthma and Clinical Stability in COPD: What Do They Mean? Are They Achievable? Chin-kook Rhee (Korea) |
||
|
From Airways to Eosinophilia: Redefining Disease Boundaries and Disciplinary Progress |
||
|
Biologics in COPD: Hope or Hype? |
||
8 November 2026 (Sunday)
Autumn Respiratory Seminar
| Time | Session |
|---|---|
|
08:45 – 09:10 |
Registration |
|
09:10 – 09:15 |
Opening Remarks |
|
09:15 – 10:45 |
Symposium (1) – What’s New in COPD Therapeutics? |
|
Precision Medicine in Type 2 COPD: Linking Inflammatory Pathways to Treatment Optimization |
|
|
Optimizing Care in At Risk COPD with Closed Triple Therapy |
|
|
Driving COPD Stability by Prioritizing Exacerbation Control: The Role of Optimized SITT |
|
|
10:45 – 11:15 |
Coffee Break and Exhibition |
|
11:15 – 12:45 |
Professor Wah-kit Lam Young Investigator Session |
|
Relationship of Diabetes Mellitus on Clinical Presentation of Pulmonary Tuberculosis in Regional Hospitals in Hong Kong |
|
|
A Retrospective Review on the Clinical Characteristics and Outcome of Patients with Severe Asthma Exacerbation Admitted to An Intensive Care Unit in Hong Kong – A Single Centre Study |
|
|
Prevalence, Risk factors, and Prognosis of Progressive Pulmonary Fibrosis (PPF) in Patients with Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Disease (non- IPF ILD): A Hong Kong Cohort Study |
|
|
Diagnostic Performance and Complications of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration (EBUS-TBNA) in a Regional Hospital of Hong Kong: A 10-year Retrospective Study (2012-2022) |
|
|
Comparing the Diagnostic Sensitivity and Specificity of Pleural Fluid N-Terminal Pro B-type Natriuretic Peptide (NT-proBNP) and Other Biochemical Gradient Criteria in Distinguishing Heart Failure and Non-heart Failure Related Pleural Effusions |
|
|
11:15 – 12:30 |
Concurrent Symposium for Allied Health Professionals – Respiratory Stewardship in an Ageing City: From Hospital to Community |
|
Community Pulmonary Rehabilitation after COPD Crisis Slashes Early Hospital Re-Admission: A Systematic Review and Meta-Analysis |
|
|
Everyday Function and Family Medicine: The Occupational Therapy Role in Primary Asthma Management |
|
|
From Waitlist to Watchlist: Optimising Sleep Study Efficiency, Reducing Wastage and Compliance Gaps |
|
|
12:45 – 14:00 |
Lunch |
|
14:00 – 15:30 |
Symposium (2) – What’s the Way Forward for Respiratory Therapeutics? |
|
Optimal Window for Initiating Pharmacological Interventions for COPD |
|
|
The Future Management of Pulmonary Fibrosis |
|
|
Unblocking the Airways: The Evolving Role of Sustained IL 5 Inhibition in Severe Asthma |
|
|
15:30 – 16:00 |
Coffee Break and Exhibition |
|
16:00 – 17:30 |
Symposium (3) – What Respiratory Physicians Can Learn from Our Non-Respiratory Colleagues? |
|
Multidisciplinary Strategy towards Implementation of Tobacco Endgame |
|
|
Allergic and Cutaneous Effects of Respiratory Disease and Lung Cancer Therapeutics |
|
|
Novel Strategies to Delabel Drug “Allergies”: From Hong Kong to Global |